Skip to main content

Day: July 5, 2024

Captor Capital to Consolidate Common Shares

TORONTO, July 05, 2024 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (the “Company” or “Captor”) announced today that the common shares of the Company will be consolidated at a ratio of 15 pre-consolidation common shares for 1 new post-consolidated common shares. No fractional post-consolidation common shares will be issued and no cash will be paid in lieu of fractional post-consolidation common shares, such that any fractional interest in common shares resulting from the Consolidation will be rounded down to the nearest whole common share. The shareholders of the Company passed a special resolution authorizing the Consolidation at a meeting of the Company’s shareholders on June 7, 2024. It is expected that the Company’s common shares will commence trading on a consolidated basis on the...

Continue reading

Notice

On 07.05.2024 AS Baltplast (a company registered in Estonia under register code 10029370, the „Bidder“) published information via the information system of Nasdaq Tallinn Stock Exchange on its intention to make a voluntary take-over bid to all the shareholders of Aktsiaselts Silvano Fashion Group („SFG“) for acquiring all the shares of SFG, which are not owned by the Bidder (the „Bid“). Respective stock exchange news is available here – https://view.news.eu.nasdaq.com/view?id=b0e2ae1e2987071994fffc27c84825a17&lang=et&src=notices. To the knowledge of SFG, the Bidder’s intention has not changed but since the arranging financing for the Bid took more time than initially expected the proceedings of the approval of the Bid by the Financial Supervision Authority were terminated upon the application of the Bidder. The Bidder intends...

Continue reading

First Hawaiian to Report Second Quarter 2024 Financial Results on July 26, 2024

HONOLULU, Hawaii, July 05, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its second quarter 2024 financial results on Friday, July 26, 2024 before the market opens.   First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time). To access the call by phone, participants will need to click on the following registration link:   https://register.vevent.com/register/BIa54af76e9f084d46ad036d683c1f6cd6, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A live webcast of the conference call, including a slide presentation,...

Continue reading

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., July 05, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of a non-qualified stock option to purchase 160,000 shares of Class A common stock to David Johnson, Vera’s new Chief Operating Officer, under Vera’s 2024 Inducement Plan. Vera also announced that on July 2, 2024, the Compensation Committee granted additional inducement awards consisting of a non-qualified stock option to purchase 139,100 shares of Class A common stock and restricted stock units (RSUs) for 61,925 shares of Class A common stock to ten new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with...

Continue reading

SRQ Announces Engagement of Market Maker

MONTREAL, July 05, 2024 (GLOBE NEWSWIRE) — SRQ Resources Inc. (TSX-V: SRQ) (“SRQ” or the “Company”) is pleased to announce that it has retained DS Market Solutions Inc. (“DS Market”) to provide equity trading advisory and liquidity provider services in accordance with TSXV policies and subject to the approval of the TSXV. DS Market will trade the securities of the Company on the TSXV for the purpose of maintaining an orderly market. In consideration of the services provided by DS Market, the Company will pay DS Market a monthly fee of $5,000 from the Company’s available cash for a minimum term of one month and renewable for successive one-month terms thereafter. Either Party may terminate the arrangement by providing written notice to that effect 30 days prior to the end of the then current term. The services provided by DS...

Continue reading

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

MIAMI, July 05, 2024 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO; FBIOP) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that its Board of Directors has paused the payment of dividends on the Company’s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) until further notice. In accordance with the terms of the Series A Preferred Stock, dividends on the Series A Preferred Stock will continue to accrue and cumulate until such dividends are authorized or declared. The Company will begin accruing the dividend as of July 1, 2024, and no dividend payment will be issued on July 31, 2024. The Company...

Continue reading

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position  

Recruitment in NATiV3 clinical trial continues in both cohorts with over 80% of the targeted number of patients enrolled in the main cohort and 100% in the exploratory cohort of NATiV3. Analysis of the baseline characteristics of all patients randomized in the main cohort of NATiV3 show a patient profile similar to patients randomized in the NATIVE Phase IIb clinical trial. A blinded analysis of all randomized patients suggests weight gain plateaus and stabilizes between week 24 and 36. First visit of the last patient of NATiV3 is anticipated to occur during the second half of 2024, and topline results are expected at the beginning of the second half of 2026. Patent portfolio strengthened with new patent secured protecting the compound until 2043. The Company is currently working on multiple fronts to secure financing to fund the continuity...

Continue reading

Nokia Corporation: Repurchase of own shares on 05.07.2024

Nokia CorporationStock Exchange Release05 July 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 05.07.2024 Espoo, Finland – On 05 July 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 391,143 3.61CEUX – –BATE – –AQEU – –TQEX – –Total 391,143 3.61* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Axalta Schedules Second-Quarter 2024 Earnings Conference Call

PHILADELPHIA, July 05, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its second-quarter 2024 financial results at 6 a.m. ET on Thursday, August 1. The release and supporting materials will be posted to Axalta’s Investor Relations site. In addition, the company will host a conference call at 8 a.m. ET on August 1. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company’s financial performance for the period. A live webcast of the conference call will be available here. A replay of the webcast will be posted shortly after the call and will remain accessible through August 1, 2025. The dial-in phone number for the conference call is 1-800-343-5172 and the conference ID...

Continue reading

Sienna Announces Second Quarter 2024 Results Release Date and Conference Call

MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2024 second quarter results after market close on Thursday, August 8, 2024. Nitin Jain, President and Chief Executive Officer, and David Hung, Executive Vice President and Chief Financial Officer, will host a conference call for the investment community the following day, Friday, August 9, 2024 at 9:00 a.m. (ET). The toll-free dial-in number for participants is 1–800–715–9871, conference ID: 9543197. A webcast of the call will be accessible via Sienna’s website. The webcast of the call will be available for replay until August 9, 2025 and archived on Sienna’s website. About Sienna Senior Living Sienna Senior Living Inc. (TSX:SIA) offers a full range of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.